Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penehyclidine for prevention of dreaming during propofol anesthesia
ChiCTR-TRC-14005033Phase 4Completed
- Sponsor
- Jinling Hospital
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of penehyclidine and propofol (2 arms), sponsored by Jinling Hospital. Primary endpoint: orexin 1. Started Jul 2014; status: completed.
02
Drugs
penehyclidinepropofol
Beyond the preview
Go deeper on ChiCTR-TRC-14005033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005033.